Dueling Records: Are Statements in Your 510(k) Putting Your Patents at Risk?
28 October 2015
Attorneys Jolene Fernandes, James Ewing, Lisamarie Collins, Jacki Lin and Linda Wu contributed an article to Bloomberg BNA’s Medical Devices Law & Industry Report, “Dueling Records: Are Statements in Your 510(k) Putting Your Patents at Risk?,” on October 28, 2015. The article laboratory developed test (LDT) providers and new U.S. Food and Drug Administration (FDA) oversight that requires LDTs providers to consider if their LDTs constitute moderate-risk or high-risk devices subject to FDA oversight. The article reviews emerging areas of regulation for LDT providers; 510(k) statements and real world consequences to patent assets; and practical solutions for mitigating risk.
Author(s)
Related Insights
01 July 2024
Labor & Employment Law Perspectives
Choosing Substance Over Form: New Jersey Supreme Court Declares That Non-Disclosure Clauses Masquerading as Non-Disparagement Provisions Are Banned
Since certain amendments in 2019, it has been widely recognized that Section 10:5-12.8 of New Jersey’s Law Against Discrimination (N.J.S.A. 10:5-12.8) prohibits non-disclosure provisions in employment agreements or employee settlement agreements if those provisions “ha[ve] the purpose or effect of concealing the details relating to a claim of discrimination, retaliation, or harassment” that could be disclosed by the current or former employee.
01 July 2024
Labor & Employment Law Perspectives
Avoiding the Summertime Blues
With summer upon us, many employers are once again scheduling summer outings for their employees.
01 July 2024
Innovative Technology Insights
IRS Issues Guidance on Reporting for Digital Assets Transactions
These new regulations provide clarity for brokers taking possession of digital assets being sold by customers and for transactions where digital assets are used to purchase real estate.